TTM
$5.01B
YoY change
-10.8%
5Y CAGR
+5.7%
Peak year (2022)
$6.50B
Cumulative gross profit
$77.28B
Gross Profit history chart for Viatris (VTRS) from 2003 to 2025
Latest: $5.01B
Gross Profit growth chart for Viatris (VTRS) from 2003 to 2025
Latest: -10.8%
Gross Profit history table for Viatris (VTRS) from 2003 to 2025
| 2025 | $5.01B | -10.8% | −$610.10M | ||
| 2024 | $5.62B | -12.7% | −$815.00M | ||
| 2023 | $6.44B | -0.9% | −$58.40M | ||
| 2022 | $6.50B | +16.5% | +$921.50M | ||
| 2021 | $5.58B | +46.9% | +$1.78B | ||
| 2020 | $3.80B | -2.6% | −$100.90M | ||
| 2019 | $3.90B | -2.6% | −$104.00M | ||
| 2018 | $4.00B | -16.3% | −$781.50M | ||
| 2017 | $4.78B | +1.8% | +$86.10M | ||
| 2016 | $4.70B | +11.4% | +$480.90M | ||
| 2015 | $4.22B | +19.5% | +$688.10M | ||
| 2014 | $3.53B | +16.0% | +$487.70M | ||
| 2013 | $3.04B | +4.5% | +$132.00M | ||
| 2012 | $2.91B | +13.5% | +$344.94M | ||
| 2011 | $2.56B | +15.6% | +$345.97M | ||
| 2010 | $2.22B | +6.9% | +$142.93M | ||
| 2009 | $2.07B | +0.2% | +$4.25M | ||
| 2008 | $2.07B | +77.6% | +$904.29M | ||
| 2007 | $1.17B | — | — | ||
| 2005 | $627.62M | +0.7% | +$4.08M | ||
| 2004 | $623.54M | -18.2% | −$138.93M | ||
| 2003 | $762.47M | — | — |
- 2025$5.01B-10.8%
- 2024$5.62B-12.7%
- 2023$6.44B-0.9%
- 2022$6.50B+16.5%
- 2021$5.58B+46.9%
- 2020$3.80B-2.6%
- 2019$3.90B-2.6%
- 2018$4.00B-16.3%
- 2017$4.78B+1.8%
- 2016$4.70B+11.4%
- 2015$4.22B+19.5%
- 2014$3.53B+16.0%
- 2013$3.04B+4.5%
- 2012$2.91B+13.5%
- 2011$2.56B+15.6%
- 2010$2.22B+6.9%
- 2009$2.07B+0.2%
- 2008$2.07B+77.6%
- 2007$1.17B—
- 2005$627.62M+0.7%
- 2004$623.54M-18.2%
- 2003$762.47M—
Gross Profit values are taken from Viatris's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Viatris (VTRS)
According to Viatris's latest reported financial statements, the company's current gross profit (TTM) is $5.01B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Viatris (VTRS) gross profit totalled $5.01B – declined 10.8% year-over-year.
Over 2020–2025 (5 years), Viatris gross profit expanded at a +5.7% compound annual rate, with mixed annual results across the window.
Viatris gross profit peaked at $6.50B in 2022; the latest annual figure is $5.01B in 2025 (22.8% below peak).
Across the available history, gross profit reached its high of $6.50B in 2022 and its low of $623.54M in 2004.
Viatris Gross Profit by Year
Viatris Gross Profit 2025: $5.01B
Viatris gross profit in 2025 was $5.01B, declined 10.8% below 2024.
Viatris Gross Profit 2024: $5.62B
2024's gross profit for Viatris came in at $5.62B, declined 12.7% below 2023.
Viatris Gross Profit 2023: $6.44B
Viatris posted gross profit of $6.44B in 2023, edged down 0.9% below 2022.
Viatris Gross Profit 2022: $6.50B
In 2022, Viatris reported gross profit of $6.50B, grew 16.5% from 2021. This figure represents the highest annual value in the available history.
Viatris Gross Profit 2021: $5.58B
Viatris gross profit in 2021 was $5.58B.
See more financial history for Viatris (VTRS).
Sector peers by Gross Profit
Healthcare peers of Viatris (VTRS), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Viatris (VTRS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation